New hope for kidney cancer: Triple-Drug combo trial launches
Disease control
Recruiting now
This study tests three different drug combinations in 120 people with advanced kidney cancer that has spread. The goal is to see which combination works best at shrinking tumors. Participants will receive either a new two-drug or three-drug combo, or the current standard treatmen…
Phase: PHASE2 • Sponsor: Brian Rini • Aim: Disease control
Last updated May 15, 2026 11:57 UTC